U.S. Crackdown on Chinese Biotech Could Harm Patients
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
- Latest
- Trending
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Reiss's viral TikTok flash mob in London's financial district taps into a popular "finance bro" trend, boosting engagement with 661,500 ...
Exploring AI's role in education: A college student reveals AI is banned for paper writing, with institutions using tools to ...
Young people are using astrology to navigate careers, with some finding success. Nova emphasizes cycles in markets and warns against ...
The Vergecast discusses Delta getting into the App Store and what it could mean for the future of the iPhone. ...
The bill to ban TikTok in the US is nearing passing into law. If it does, the consequences for the ...
The rise of AI and social discovery is fundamentally changing how people search, posing new challenges for marketers to adapt ...
Chinese regulator's order precedes US Senate vote on bill that could result in TikTok ban; ByteDance will have a year ...
Music League is a social platform that creates playlists through a league format, offering a break from algorithm-driven music recommendations. ...
House Speaker Mike Johnson's move to combine the legislation could make the TikTok bill harder for the Senate to ignore, ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.